Stay updated on CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial
Sign up to get notified when there's something new on the CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial page.

Latest updates to the CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedNew user guidance sections were added and a recruitment status note indicates recruitment has ended. The heading for the intervention section was updated from 'Intervention / Treatment' to 'Intervention/Treatment', and a new revision stamp 'Revision: v3.6.0' appears.SummaryDifference0.3%

- Check17 days agoChange DetectedThe page now displays a new revision label, indicating a minor update to the page template or system. This does not appear to modify any study details or actionable content.SummaryDifference0.0%

- Check39 days agoChange DetectedA new revision label Revision: v3.5.4 was added and an older label Revision: v3.5.3 was removed, indicating a small version update to the page's text. This update appears to be a release-note style change rather than a modification to study details.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page’s revision label was updated from v3.5.2 to v3.5.3, indicating a new revision of the page content. This change is a metadata-level patch rather than a substantive update to the study information.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision metadata updated: added Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check96 days agoChange DetectedThe page now shows Revision: v3.5.0, replacing Revision: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial page.